Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 10, 2022 at 05:03 pm EST
Share
Microbio Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 379.39 million compared to TWD 449.09 million a year ago. Revenue was TWD 386.66 million compared to TWD 459.29 million a year ago. Net income was TWD 425.05 million compared to TWD 19.22 million a year ago. Basic earnings per share from continuing operations was TWD 0.7573 compared to TWD 0.0365 a year ago. Diluted earnings per share from continuing operations was TWD 0.7573 compared to TWD 0.0365 a year ago.
For the nine months, sales was TWD 1,248.8 million compared to TWD 1,311.01 million a year ago. Revenue was TWD 1,271.96 million compared to TWD 1,339.04 million a year ago. Net income was TWD 671.35 million compared to net loss of TWD 329.5 million a year ago. Basic earnings per share from continuing operations was TWD 1.1953 compared to basic loss per share from continuing operations of TWD 0.6022 a year ago. Diluted earnings per share from continuing operations was TWD 1.1953 compared to diluted loss per share from continuing operations of TWD 0.6022 a year ago.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
MICROBIO CO., LTD. 
